Pharmacokinetics part 1 l.jpg
Sponsored Links
This presentation is the property of its rightful owner.
1 / 55

Pharmacokinetics -- part 1 -- PowerPoint PPT Presentation

  • Updated On :
  • Presentation posted in: General

Pharmacokinetics -- part 1 --. W.M. Tom Department of Pharmacology University of Hong Kong. Pharmacokinetics . -- refers to the action of the body on the drug, including: absorption distribution elimination -- metabolism & excretion. Drug Disposition. Drug Absorption .

Download Presentation

Pharmacokinetics -- part 1 --

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript

Pharmacokinetics-- part 1 --

W.M. Tom

Department of Pharmacology

University of Hong Kong


-- refers to the action of the body on the drug, including:



elimination -- metabolism & excretion

Drug Disposition

Drug Absorption

Peroral administration (P.O. route)


commonly known as “oral administration”

most convenient and economic method of systemic drug delivery

dosage forms, e.g. tablets, capsules, syrups, etc.

Drug absorption

Solids are not absorbed!

Dissolution is usually the rate limiting step!

Drug Absorption

Peroral administration (P.O. route)

drug release  formulation (e.g. tablets)e.g. particle size, surface area, excipients (inert substances)


DISSOLUTION (solution)


SYSTEMIC CIRCULATION (% bioavailability)

Drug absorptionstomach (pH 1~3)in favour of weak acid absorptionduodenum (pH 5~7)in favour of weak base absorptionileum (pH 7~8)in favour of weak base absorption

Diffusion Across Membrane

(pH < pKa )




(pH > pKa )


(pH > pKa )




(pH < pKa )


Drug Absorption

Factors affecting drug absorption by enteral routes

1. Drug dissolution

-- depends on drug formulation of oral preparations

2. pH environment in GI tract

-- unionized form efficiently absorbed

3. Lipid solubility of the drug

-- nonpolar form easily absorbed

Drug Absorption

Factors affecting drug absorption by enteral routes

4. Effects of food

-- in general delays drug absorption

5. First pass effect

-- absorption of a drug into the portal circulation

-- drug metabolized by liver before it reaches the systemic circulation

First-pass effectmouthesophagusstomachsmall intestinecolonrectum

First - Pass Effect

Drug Absorption

Parenteral routes

1. intravenous injection (IV)

-- directly into a vein

-- 100% bioavailability

2. intramuscular injection (IM) -- into a muscle

-- depends on blood supply

Drug Absorption

Parenteral routes

3. subcutaneous injection (SC)

-- under the skin

-- intended for slow absorption

4. others-- inhalation

-- sublingual

-- topical

-- transdermal, etc.

Absorption, distribution, metabolism and excretion

Drug Distribution

Drug transfer to various tissues

-- depends on drug lipophilicity and blood flow

Drug barriers

-- e.g. blood-brain barrier, placenta

Drug binding to plasma proteins

-- bound drugs are pharmacologically inactive

-- unbound drugs are free to distribute to target tissues

-- different drugs may compete for binding to plasma proteins and displace each other from binding sites











Free Drug



Bound Drug


Saturation of Protein Binding Sites

Drug displacement from protein binding sites

Plasma Protein Binding

consequence of drug displacement

an increase in free drug concentration of the displaced drug  an increase in drug effect

(be cautious when using a drug of low T.I.)

a decrease in the duration of action of the displaced drug because more free drugs are available for elimination

Drug Metabolism

modification of the chemical structure by enzyme systems in the body

-- e.g. cytochrome P450 in liver

these chemical reactions produce water-soluble metabolites which are more readily excreted by the kidneys

-- phase I reaction, e.g. oxidation

-- phase II (conjugation) reaction, e.g. glucuronidation

drug metabolism activity can be influenced by a variety of drugs

The two phases of drug metabolism

The two phases of drug metabolism

Proportion of drugs metabolized by the major phase I and phase II enzymes

Drug Metabolism

enzyme induction

-- results in faster rate of metabolism

-- e.g. in heavy cigarette smokers, alcoholics

enzyme inhibition

-- results in slower rate of metabolism

-- e.g. taking another drug which uses the same enzyme for metabolism

biological variations in drug metabolism

-- e.g. genetics, disease states, age, etc.

Drug Excretion

in urine

-- by glomerular filtration and renal tubular secretion -- polar water-soluble metabolites readily excreted while nonpolar forms reabsorbed back to circulation

in bile and feces

other routes

-- e.g. in sweat, milk and other body fluids

-- volatile gases by exhalation

Renal excretion of drugs-- lipid-soluble and un-ionized drugs are passively reabsorbed through the nephron-- active secretion of organic acids and bases occurs only in the proximal tubular segment-- in distal tubular segments, the secretion of H+ favours reabsorption of weak acids (less ionized) and excretion of weak bases (more ionized)

Part 1 ended

Pharmacokinetics-- part 2 --

W.M. Tom

Department of Pharmacology

University of Hong Kong

Time course of action of a single oral dose Time of onset = T1 - T0Time to peak effect = T2 - T0Duration of action = T3 - T1MEC = minimum effective concentration

Time course of drug action

time of onset

-- the time taken for the drug to produce a response

time to peak effect

-- the time taken for the drug to reach its highest blood concentration

duration of action

-- the time during which the drug produces a response

elimination half-life ( t 1/2 )

-- the time taken to reduce the drug concentration in the blood by 50%

One Compartment IV Bolus Pharmacokinetic Model


drug is mixed instantaneously in blood

drug in the blood is in rapid equilibrium with drug in the extravascular tissues

drug elimination follows first order kinetics

One Compartment IV Bolus Pharmacokinetic Model

rate of concentration change at each time point:


——— = – k • Cp


…. (1)

Cp : plasma drug concnetration

k : elimination rate constant

One Compartment IV Bolus Pharmacokinetic Model

Ct = C0 • e – k • t………. (2)

Ct : plasma concentration at time t

C0 : plasma concentration at time 0

One Compartment IV Bolus Pharmacokinetic Model

k • t

log Ct = log C0 – ————— ………. (3)


Ct : plasma concentration at time t

C0 : plasma concentration at time 0

One Compartment IV Bolus Pharmacokinetic Model

Apparent volume of distribution (Vd )

apparent volume that the drug is distributed into

not a physiological volume

amount of drug in the body X

Vd = ———————————— = ——

drug conc. In plasma Cp


orVd = ————— ………………. (4)


One Compartment IV Bolus Pharmacokinetic Model


Vd = ————— ………………. (4)


substitute (4) to (3), I.e. Ct = C0 • e – k • t


Ct = ————— • e– k • t………. (5)


One Compartment IV Bolus Pharmacokinetic Model

Half-Life of Elimination ( t 1/2 )

time taken for the plasma concentration to fall to half its original value


t 1/2 = ————— ………………. (6)


One-compartment pharmacokinetics (single dose, IV)Cp = plasma drug concentrationC0 = plasma concentration at time zerok el = elimination constantelimination half-life t 1/2 = t 2 - t 1

One Compartment IV Bolus Pharmacokinetic Model

Drug clearance ( CL )

a measure of he efficiency with which a drug is removed from the body

rate of elimination amount of drug • k

CL = ———————— = —————————

Cp Cp

= Vd • k………………. (7)

CL total = CL kidney + CL liver + CL others

One Compartment IV Bolus Pharmacokinetic Model

Bioavailability ( F )

measures the extent of absorption of a given drug, usually expressed as fraction of the administered dose

intravenous injection, by definition, has a bioavailability of 100%


F = —————————————— ….. (8)


AUC : area under the conc.-time curve






i.v. route

oral route

Time (hours)

Multiple IV Bolus Dose Administration

drug accumulation occurs when repeated doses are given before the drug is completely eliminated

repeated drug administration at dose intervals (t ) will give a steady state with the plasma concentration fluctuating between a maximum (Cmax) and a minimum (Cmin ) value

Plateau principleCss = steady state concentrationCmax = maximum CssCmin = minimum CssMEC = minimum effective concentrationMTC = minimum toxic concentrationtherapeutic range = MTC - MEC

Time course of drug action

plateau principle

-- repeated drug administration at fixed dosage intervals will produce a plateau concentration of drug in the blood (I.e. steady state)

steady state

-- a state at which the rate of drug administration is equal to the rate of elimination

therapeutic range

-- the range between the minimum effective concentration (MEC) and the minimum toxic concentration (MTC) of a drug

Effect of dosage intervals on drug concentration curve 1 -- dosage interval too short; curve 2 -- too long; curve 3 -- ideal

Blood levels of drugs with intermittent dosage a typical oral dosage four times a day on a schedule of 10-2-6-10 or 9-1-5-9

Time course of drug action

loading dose

-- a large dose given to achieve therapeutic concentration rapidly

maintenance dose

-- a dose given to maintain the drug concentration at steady state

Combined Infusion and Bolus Administration

to achieve a therapeutic concentration more quickly is to give a loading dose by rapid IV injection and then start the slower maintenance infusion

Loading dose = Css Vd ........... (9)

Maintenance dose = CL  Cp ………. (10)

Multi-compartment Pharmacokinetic Model

the drug appears to distribute between 2 or more compartments

the drug is not instantaneously equilibrated in various tissues

rapidly perfused tissues often belong to the central compartment

slowly perfused tissues belong to the peripheral compartment

Two-compartment pharmacokinetics (single dose, IV) central compartment (rapid) t 1/2 peripheral compartment (slow) t 1/2

Part 2 ended

  • Login